
Blue Water (NASDAQ: BWV) Vaccines Announces Publication in Nano Research Supporting Novel S&P Vaccine Platform Versatility
Blue Water Vaccines has exclusive, global licensing rights to Cincinnati Children’s Hospital Medical Center’s novel virus-like particle (VLP) vaccine platform. The data supports BWV’s ongoing development of a transformational universal influenza vaccine, as well as […]